PTCB PTCE Question Answer
Varenicline is indicated for:
Smoking cessation.
Ulcerative colitis.
Seasonal affective disorder.
Somnambulism.
Varenicline is a partial agonist at α4β2 nicotinic acetylcholine receptors indicated for smoking cessation to aid in quitting tobacco use. It is not indicated for ulcerative colitis, seasonal affective disorder, or sleepwalking.
References (Pharmacy Technician documents/Study Guides):
• FDA-approved indications for varenicline; pharmacology overview in technician certification guides.
• PTCB/ExCPT drug indications: smoking cessation therapies (varenicline, bupropion SR, NRTs).
• Standard pharmacy references on CNS agents used for tobacco cessation.
TESTED 20 Dec 2025
Copyright © 2014-2025 ACE4Sure. All Rights Reserved